Sarepta Therapeutics' (SRPT) Rating Downgrade Dents Share Price
We recently published a list of 10 Stocks Investors Dumped Fast.
Sarepta Therapeutics Inc. (SRPT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 2,674,835 | $170,707,970 | +5% | 2.66% |
| 2. | Farallon Capital Thomas Steyer | 2,341,424 | $149,429,680 | -19% | 0.83% |
| 3. | EcoR1 Capital Oleg Nodelman | 1,292,386 | $82,480,075 | +68% | 4.89% |
| 4. | Casdin Capital Eli Casdin | 900,783 | $57,487,971 | -17% | 4.7% |
| 5. | Deep Track Capital David Kroin | 899,731 | $57,420,832 | 1.86% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $134.66 | 5,648 | 284,034 | 2024-08-16 | Filing | ||
| $134.06 | 18,284 | 278,386 | 2024-08-16 | Filing | ||
| $133.07 | 13,106 | 260,102 | 2024-08-16 | Filing | ||
| $78.81 | 40,000 | Director | 140,000 | 2023-11-03 | Filing | |
| $78.81 | 10,000 | Director | 10,000 | 2023-11-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $99.64 | 2,491 | 27,812 | 2025-03-12 | Filing | ||
| $124.84 | 10,500 | 22,840 | 2024-12-12 | Filing | ||
| $125.55 | 1,636 | 5,880 | 2024-12-05 | Filing | ||
| $137.36 | 5,985 | 33,946 | 2024-08-30 | Filing | ||
| $164.52 | 2,549 | 17,129 | 2024-06-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,906,868 | $632,256,316 | 0.01% | |
| 2. | 9,060,772 | $578,292,911 | 0.11% | |
| 3. | 9,032,613 | $576,461,361 | 0.01% | |
| 4. | 4,068,472 | $259,649,883 | 0.01% | |
| 5. | 3,364,845 | $236,884,912 | 0.13% |
News See All
The FDA granted Sarepta’s rAAVrh74 Viral Vector a Platform Technology Designation
The FDA has designated the viral vector rAAVrh74, which Sarepta Therapeutics, Inc.
Was Jim Cramer Right About Sarepta Therapeutics Inc. (SRPT)?
We recently published a list of Was Jim Cramer Right About These 11 Stocks? In this article, we are going to take a look at where Sarepta Therapeutics Inc.
Was Jim Cramer Right About These 11 Stocks?
"We temporarily forgot who was in charge, who determines stock prices, who decides whether we're going to have an up day or a down day. No, I'm not talking about the invisible hand of the market.
Billionaire Glenn Russell Dubin's 10 Stock Picks with Huge Upside Potential
Glenn Russell Dubin is one of the industry's most experienced hedge fund managers, best known as the co-founder of Highbridge Capital Management, a multi-strategy investment business he founded with Henry...
11 Stocks That Will Bounce Back According to Analysts
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Sarepta Therapeutics First Quarter 2025 Financial Results Conference Call. As a reminder, today's program is being recorded.
11 Oversold NASDAQ Stocks to Buy Right Now
On April 28, Darrell Cronk, Wells Fargo Wealth and Investment Management CIO, appeared on CNBC's 'Squawk on the Street' to discuss market outlooks and what investors should look at in the current market...
Billionaire George Soros' 10 Small-Cap Stocks with Huge Upside Potential
When a legendary investor like George Soros makes a move, Wall Street pays attention.
11 Most Promising Long-Term Stocks According to Analysts
On March 31, Banrion's Shana Sissel recently appeared on CNBC's 'Power Lunch' to discuss that buying at lower valuations is favorable for long-term investors.
Billionaire Hedge Funds
